iFabric Corp. Provides Update on Important Milestones and Developments

iFabric Corp. (TSX VENTURE:IFA), hereinafter referred to as "iFabric" or the
"Company", is pleased to provide this update with regard to important milestones
and developments recently achieved by its wholly-owned subsidiary company,
Intelligent Fabric Technologies (North America) Inc. ("IFTNA").


Shipments to US Fabric Finishers

IFTNA has commenced shipping Cliniweave to dye-houses in the USA for use in
programs for The North Face, Under Armour and other global brands. "Whilst we
believe that Asian producers will comprise our main market for the manufacture
of Cliniweave infused products, US apparel manufacturers still produce
significant volumes of apparel for the North American market so the importance
of working with US dye- houses cannot be underestimated" said Hylton Karon,
President and CEO of iFabric. "We anticipate modest shipments of Cliniweave to
the US until the end of 2013 after which, we expect to see a steady increase in
volumes as Cliniweave is integrated into future programs" he added.


Plastics Development

IFTNA has developed a universal Cliniweave plastics matrix for incorporating
Cliniweave into plastics commonly used in a variety of industries. "We have
devoted significant resources on Cliniweave plastics integration as we see this
as an important market for us" said Mr. Karon. "We are very encouraged by the
efficacy shown by laboratory testing of Cliniweave infused plastics to date. Our
initial target markets are medical devices, food services, computing components
and packaging and storage products, amongst others" added Mr. Karon.


"We have commenced shipping Cliniweave PM to Instore Corp. ("Instore") for use
in reusable shopping bags to be supplied to major grocery chains in the US and
Canada. Instore is a market leader in the design and manufacture of unique
products that support the needs of the global grocery industry and we are
excited to be working with them" concluded Mr Karon.


Cliniweave Laundry Additive

IFTNA has successfully completed the development of an industrial laundry
additive for use within normal laundering protocols. Recent laboratory testing
against the Norwalk virus, (commonly referred to as Norovirus) has shown that
fabrics laundered with the inclusion of the Cliniweave AV additive in the
laundering process are highly effective in destroying the virus. "Our target
market here is the cruise line industry, whose problems with Norovirus have been
well documented and we are hoping to do an onboard trial with a major cruise
line within the next 12 months to determine whether the Cliniweave AV additive
can prove to be a significant tool in the reduction of onboard instances of
Norovirus infection" said Mr. Karon.


ABOUT CLINIWEAVE:

CLINIWEAVE provides long-term effective control against a wide range of common
pathogens, including mold, mildew, fungi and odor causing bacteria. Its efficacy
and safety has been documented in peer reviewed publications and certified
laboratory tests. It is durable through repeated washing and is proven to kill
bacteria associated with hospital acquired infections. Medical facility uses for
Cliniweave include bedding, curtaining, air filters, scrubs, masks and surfaces
amongst others.


ABOUT iFABRIC CORP:

iFABRIC CORP currently has 25.4 million shares issued and outstanding. iFABRIC
is a manufacturer, distributor, licensor and licensee of ladies intimate apparel
products and accessories as well proprietary chemical compounds that render
fabrics intelligent, thereby improving the safety and well-being of the wearer.


FORWARD LOOKING STATEMENTS:

Forward-looking statements provide an opinion as to the effect of certain events
and trends on the business. Certain statements contained in this news release
constitute forward-looking statements. The use of any words such as
"anticipate", "continue", "estimate", "expect", "may", "will", "project",
"should", "believe" and similar expressions are intended to identify
forward-looking statements. These forward-looking statements are based on
current expectations and various estimates, factors and assumptions and involve
known and unknown risks, uncertainties and other factors. Forward-looking
information includes, but is not limited to, statements with respect to the
development potential of the Company's products.


Forward-looking statements are based on the opinions and estimates of management
as of the date such statements are made. Readers are cautioned not to place
undue reliance on these statements as the Company's actual results, performance,
or achievements may differ materially from any future results, performance or
achievements expressed or implied by such forward-looking statements if known or
unknown risks, uncertainties or other factors affect the Company's business, or
if the Company's estimates or assumptions prove inaccurate. Therefore, the
Company cannot provide any assurance that forward-looking statements will
materialize. The Company assumes no obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or any other reason except as required by applicable securities laws.


Any financial outlook or future oriented financial information in this news
release, as defined by applicable securities legislation, has been approved by
management of iFabric. Such financial outlook or future oriented financial
information is provided for the purpose of providing information about
management's reasonable expectations as to the anticipated results of its
proposed business activities. Readers are cautioned that reliance on such
information may not be appropriate for other purposes. The forward-looking
statements contained in this press release are made as of the date hereof and
the Company undertakes no obligation to update publicly or revise any
forward-looking statements or information, whether as a result of new
information, future events or otherwise, unless so required by applicable
securities laws.


Neither the TSX Venture Exchange nor its Regulations Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this press release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
iFabric Corp.
Hilton Price
CFO
905 882-4513
[e-mail]
www.ifabriccorp.com